BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Boland ML, Oró D, Tølbøl KS, Thrane ST, Nielsen JC, Cohen TS, Tabor DE, Fernandes F, Tovchigrechko A, Veidal SS, Warrener P, Sellman BR, Jelsing J, Feigh M, Vrang N, Trevaskis JL, Hansen HH. Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source. World J Gastroenterol 2019; 25(33): 4904-4920 [PMID: 31543682 DOI: 10.3748/wjg.v25.i33.4904]
URL: https://www.wjgnet.com/1007-9327/full/v25/i33/4904.htm
Number Citing Articles
1
Emma L. Shepherd, Raquel Saborano, Ellie Northall, Kae Matsuda, Hitomi Ogino, Hiroaki Yashiro, Jason Pickens, Ryan E. Feaver, Banumathi K. Cole, Stephen A. Hoang, Mark J. Lawson, Matthew Olson, Robert A. Figler, John E. Reardon, Nobuhiro Nishigaki, Brian R. Wamhoff, Ulrich L. Günther, Gideon Hirschfield, Derek M. Erion, Patricia F. Lalor. Ketohexokinase inhibition improves NASH by reducing fructose-induced steatosis and fibrogenesisJHEP Reports 2021; 3(2): 100217 doi: 10.1016/j.jhepr.2020.100217
2
Xiankang Fang, Zhiqiang Du, Chunling Duan, Shanshan Zhan, Tian Wang, Mengyu Zhu, Jiajie Shi, Juan Meng, Xianhua Zhang, Maiyun Yang, Yajun Zuo. Beinaglutide shows significantly beneficial effects in diabetes/obesity-induced nonalcoholic steatohepatitis in ob/ob mouse modelLife Sciences 2021; 270: 118966 doi: 10.1016/j.lfs.2020.118966
3
Leo Sungwong Choi, In Geun Jo, Ku Suk Kang, Jeong Ho Im, Jiyoung Kim, Jinyoung Kim, Jin Wook Chung, Sang-Ku Yoo. Discovery and preclinical efficacy of HSG4112, a synthetic structural analog of glabridin, for the treatment of obesityInternational Journal of Obesity 2021; 45(1): 130 doi: 10.1038/s41366-020-00686-1
4
Olga Estévez-Vázquez, Raquel Benedé-Ubieto, Feifei Guo, Beatriz Gómez-Santos, Patricia Aspichueta, Johanna Reissing, Tony Bruns, Carlos Sanz-García, Svenja Sydor, Lars P. Bechmann, Eva Maranillo, José Ramón Sañudo, María Teresa Vázquez, Arantza Lamas-Paz, Laura Morán, Marina S. Mazariegos, Andreea Ciudin, Juan M. Pericàs, María Isabel Peligros, Javier Vaquero, Eduardo Martínez-Naves, Christian Liedtke, José R. Regueiro, Christian Trautwein, Rafael Bañares, Francisco Javier Cubero, Yulia A. Nevzorova. Fat: Quality, or Quantity? What Matters Most for the Progression of Metabolic Associated Fatty Liver Disease (MAFLD)Biomedicines 2021; 9(10): 1289 doi: 10.3390/biomedicines9101289
5
James M. Eng, Jennifer L. Estall. Diet-Induced Models of Non-Alcoholic Fatty Liver Disease: Food for Thought on Sugar, Fat, and CholesterolCells 2021; 10(7): 1805 doi: 10.3390/cells10071805
6
Yuan Xie, Lu Chen, Zhipeng Xu, Chen Li, Yangyue Ni, Min Hou, Lin Chen, Hao Chang, Yuxuan Yang, Huiquan Wang, Rongbo He, Rourou Chen, Li Qian, Yan Luo, Ying Zhang, Na Li, Yuxiao Zhu, Minjun Ji, Yu Liu. Predictive Modeling of MAFLD Based on Hsp90α and the Therapeutic Application of Teprenone in a Diet-Induced Mouse ModelFrontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.743202
7
Vitor de Miranda Ramos, Alicia J. Kowaltowski, Pamela A. Kakimoto. Autophagy in Hepatic Steatosis: A Structured ReviewFrontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.657389
8
Bader Zarrouki, Jeremie Boucher. Kupffer CellsMethods in Molecular Biology 2020; 2164: 121 doi: 10.1007/978-1-0716-0704-6_13
9
Jia Han, Xin Guo, Tomoyuki Koyama, Daichi Kawai, Jing Zhang, Reimon Yamaguchi, Xiaolei Zhou, Yoshiharu Motoo, Takumi Satoh, Sohsuke Yamada. Zonarol Protected Liver from Methionine- and Choline-Deficient Diet-Induced Nonalcoholic Fatty Liver Disease in a Mouse ModelNutrients 2021; 13(10): 3455 doi: 10.3390/nu13103455
10
Simon T. Hui, Feng Wang, Frank Stappenbeck, Samuel W. French, Clara E. Magyar, Farhad Parhami, Aldons J. Lusis. Oxy210, a novel inhibitor of hedgehog and TGF‐β signalling, ameliorates hepatic fibrosis and hypercholesterolemia in miceEndocrinology, Diabetes & Metabolism 2021; 4(4) doi: 10.1002/edm2.296
11
Maria E. Moreno-Fernandez, Daniel A. Giles, Jarren R. Oates, Calvin C. Chan, Michelle S.M.A. Damen, Jessica R. Doll, Traci E. Stankiewicz, Xiaoting Chen, Kashish Chetal, Rebekah Karns, Matthew T. Weirauch, Lindsey Romick-Rosendale, Stavra A. Xanthakos, Rachel Sheridan, Sara Szabo, Amy S. Shah, Michael A. Helmrath, Thomas H. Inge, Hitesh Deshmukh, Nathan Salomonis, Senad Divanovic. PKM2-dependent metabolic skewing of hepatic Th17 cells regulates pathogenesis of non-alcoholic fatty liver diseaseCell Metabolism 2021; 33(6): 1187 doi: 10.1016/j.cmet.2021.04.018
12
Koichi Fujisawa, Taro Takami, Shoki Okubo, Yuto Nishimura, Yusaku Yamada, Keisuke Kondo, Toshihiko Matsumoto, Naoki Yamamoto, Isao Sakaida. Establishment of an Adult Medaka Fatty Liver Model by Administration of a Gubra-Amylin-Nonalcoholic Steatohepatitis Diet Containing High Levels of Palmitic Acid and FructoseInternational Journal of Molecular Sciences 2021; 22(18): 9931 doi: 10.3390/ijms22189931
13
Helene M. Ægidius, Sanne S. Veidal, Michael Feigh, Philip Hallenborg, Michele Puglia, Tune H. Pers, Niels Vrang, Jacob Jelsing, Birgitte R. Kornum, Blagoy Blagoev, Kristoffer T. G. Rigbolt. Multi-omics characterization of a diet-induced obese model of non-alcoholic steatohepatitisScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-58059-7
14
Hannah Zhang, Mélissa Léveillé, Emilie Courty, Aysim Gunes, Bich N. Nguyen, Jennifer L. Estall. Differences in metabolic and liver pathobiology induced by two dietary mouse models of nonalcoholic fatty liver diseaseAmerican Journal of Physiology-Endocrinology and Metabolism 2020; 319(5): E863 doi: 10.1152/ajpendo.00321.2020
15
Aimo Kannt, Andreas Nygaard Madsen, Claire Kammermeier, Ralf Elvert, Tim Klöckener, Martin Bossart, Torsten Haack, Andreas Evers, Katrin Lorenz, Wolfgang Hennerici, Corinne Rocher, Zsolt Böcskei, Jean‐Claude Guillemot, Vincent Mikol, Francois Pattou, Bart Staels, Michael Wagner. Incretin combination therapy for the treatment of non‐alcoholic steatohepatitisDiabetes, Obesity and Metabolism 2020; 22(8): 1328 doi: 10.1111/dom.14035
16
Aimo Kannt, Efstathia Papada, Claire Kammermeier, Giuseppe D'Auria, Nuria Jiménez‐Hernández, Martin Stephan, Uwe Schwahn, Andreas Nygaard Madsen, Mette Viberg Østergaard, George Dedoussis, M. Pilar Francino. Mastiha ( Pistacia lentiscus ) Improves Gut Microbiota Diversity, Hepatic Steatosis, and Disease Activity in a Biopsy‐Confirmed Mouse Model of Advanced Non‐Alcoholic Steatohepatitis and Fibrosis Molecular Nutrition & Food Research 2019; 63(24): 1900927 doi: 10.1002/mnfr.201900927
17
Sridhar Radhakrishnan, Jia-Yu Ke, Michael A Pellizzon. Targeted Nutrient Modifications in Purified Diets Differentially Affect Nonalcoholic Fatty Liver Disease and Metabolic Disease Development in Rodent ModelsCurrent Developments in Nutrition 2020; 4(6) doi: 10.1093/cdn/nzaa078
18
Anurag Mishra, Tamara R. Castañeda, Erik Bader, Bettina Elshorst, Sheila Cummings, Petra Scherer, Dinesh S. Bangari, Claudia Loewe, Herman Schreuder, Christoph Pöverlein, Mike Helms, Seth Jones, Gernot Zech, Thomas Licher, Michael Wagner, Manfred Schudok, Meltsje Hoop, Alleyn T. Plowright, Jens Atzrodt, Aimo Kannt, Iina Laitinen, Volker Derdau. Triantennary GalNAc Molecular Imaging Probes for Monitoring Hepatocyte Function in a Rat Model of Nonalcoholic SteatohepatitisAdvanced Science 2020; 7(24): 2002997 doi: 10.1002/advs.202002997
19
Lorenz M. W. Holzner, Andrew J. Murray. Hypoxia-Inducible Factors as Key Players in the Pathogenesis of Non-alcoholic Fatty Liver Disease and Non-alcoholic SteatohepatitisFrontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.753268
20
Yvonne Oligschlaeger, Ronit Shiri-Sverdlov. NAFLD Preclinical Models: More than a Handful, Less of a Concern?Biomedicines 2020; 8(2): 28 doi: 10.3390/biomedicines8020028
21
Henrik H. Hansen, Helene M. Ægidius, Denise Oró, Simon S. Evers, Sara Heebøll, Peter Lykke Eriksen, Karen Louise Thomsen, Anja Bengtsson, Sanne S. Veidal, Michel Feigh, Malte P. Suppli, Filip K. Knop, Henning Grønbæk, Diego Miranda, James L. Trevaskis, Niels Vrang, Jacob Jelsing, Kristoffer T. G. Rigbolt. Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitisBMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01356-2
22
Cheng Peng, Alastair G. Stewart, Owen L. Woodman, Rebecca H. Ritchie, Cheng Xue Qin. Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical TreatmentsFrontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.603926